Anavex Life Sciences
AVXL
149 hedge funds and large institutions have $383M invested in Anavex Life Sciences in 2021 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 52 increasing their positions, 32 reducing their positions, and 19 closing their positions.
68% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 19
63% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 32
26% more call options, than puts
Call options by funds: $19.2M | Put options by funds: $15.2M
10% more funds holding
Funds holding: 136 → 149 (+13)
1.86% more ownership
Funds ownership: 27.22% → 29.08% (+1.9%)
4% more capital invested
Capital invested by funds: $370M → $383M (+$13.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$15.8M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$7.58M |
| 3 |
Goldman Sachs
New York
|
+$5.18M |
| 4 |
Barclays
London,
United Kingdom
|
+$3.65M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$2.22M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$6.3M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.85M |
| 3 |
Voloridge Investment Management
Jupiter,
Florida
|
-$2.71M |
| 4 |
Nomura Holdings
Tokyo,
Japan
|
-$2.42M |
| 5 |
KPWS
Kestra Private Wealth Services
Austin,
Texas
|
-$1.8M |
AVXL Hedge Fund Activity: Q4 2021 in Review
149 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q4 2021, worth a combined $383M — up 3.6% from $370M a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new AVXL positions and 19 closed out — a net gain of 13 holders — while 52 added to existing stakes and 32 trimmed.
The largest buyer was BlackRock, adding an estimated $15.8M. The largest seller was State Street, cutting an estimated $6.3M.
- 149 institutional investors held Anavex Life Sciences (AVXL) as of Q4 2021, up from 136 in Q3 2021.
- Funds reported $383M of Anavex Life Sciences stock for Q4 2021, up 3.6% quarter-over-quarter.
- 32 funds opened new Anavex Life Sciences positions in Q4 2021 and 19 closed out, a net change of +13 holders.
- The largest Anavex Life Sciences buyer in Q4 2021 was BlackRock, an estimated $15.8M added.
- The largest Anavex Life Sciences seller in Q4 2021 was State Street, an estimated $6.3M sold.
Based on aggregated 13F filings for Q4 2021.